RT @Atarabio@twitter.com

Alongside @PierreFabre@twitter.com we're proud to announce @EMA_News@twitter.com approved our allogeneic T-cell therapy to treat adult & pediatric patients 2 years of age & older with r/r #EBV+ #PTLD, marking the first ever approval of an off-the-shelf T-cell immunotherapy. More: https://bit.ly/3HQF4rM

🐦🔗: https://twitter.com/Atarabio/status/1604809054383120385